Search research articles
Contact Us
Filters
Showing results (71-80 of 166) with videos related to
Page
of 17
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 17, 1999
Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology
M Filippi, M Rovaris, R Capra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1990
Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging
G P Anzola, L Bevilacqua, S F Cappa, et al.
Journal of the Neurological Sciences
|
September 6, 2017
Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237]
C Scarpazza, L Prosperini, C R Mancinelli, et al.
Neurology
|
September 26, 2008
Cognitive impairment and structural brain damage in benign multiple sclerosis
M Rovaris, G Riccitelli, E Judica, et al.
Brain : a Journal of Neurology
|
November 10, 2001
In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis
M Rovaris, M Bozzali, G Santuccio, et al.
Brain : a Journal of Neurology
|
November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials
M Filippi, M Rovaris, R Capra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
August 10, 2004
Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families
C Mariotti, C Gellera, M Rimoldi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 17, 2011
Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy
M Chiarini, F Serana, C Zanotti, et al.
Neurology
|
September 8, 2010
Safety and efficacy of natalizumab in children with multiple sclerosis
A Ghezzi, C Pozzilli, L M E Grimaldi, et al.
Medical Physics
|
October 23, 2010
Comparison of GEANT4 very low energy cross section models with experimental data in water
S Incerti, A Ivanchenko, M Karamitros, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 166) with videos related to
Sort By:
Page
of 17
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 17, 1999
Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology
M Filippi, M Rovaris, R Capra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1990
Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging
G P Anzola, L Bevilacqua, S F Cappa, et al.
Journal of the Neurological Sciences
|
September 6, 2017
Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237]
C Scarpazza, L Prosperini, C R Mancinelli, et al.
Neurology
|
September 26, 2008
Cognitive impairment and structural brain damage in benign multiple sclerosis
M Rovaris, G Riccitelli, E Judica, et al.
Brain : a Journal of Neurology
|
November 10, 2001
In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis
M Rovaris, M Bozzali, G Santuccio, et al.
Brain : a Journal of Neurology
|
November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials
M Filippi, M Rovaris, R Capra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
August 10, 2004
Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families
C Mariotti, C Gellera, M Rimoldi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 17, 2011
Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy
M Chiarini, F Serana, C Zanotti, et al.
Neurology
|
September 8, 2010
Safety and efficacy of natalizumab in children with multiple sclerosis
A Ghezzi, C Pozzilli, L M E Grimaldi, et al.
Medical Physics
|
October 23, 2010
Comparison of GEANT4 very low energy cross section models with experimental data in water
S Incerti, A Ivanchenko, M Karamitros, et al.
Page
of 17